Stage IV includes T4b, NO,MO/any T NI, MO/ any T N2 MO,/ any T N3 MO/ any T any N M1 : T4b: Tumor invades the pelvic wall, abdominal wall. N1: Metastasis in a single lymph node, 2 cm or less in greate...
Comprehensive, easy-to-understand information about this condition
How we create this content →Report Generation Failed
We couldn't automatically generate the report. This may be due to temporary service issues.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
Organizations with orphan designations or approved therapies for this disease
Akeso Biopharma, Inc.
Other
Array BioPharma Inc.
Other
Array BioPharma Inc., a wholly-owned subsidiary of Pfizer Inc.
Other
Ascentage Pharma Group Inc.
Other
Bayer Corporation
Other
BioMed Valley Discoveries, Inc.
Other
BioNTech SE
Other
BioVex, Inc. (subsidiary of Amgen)
Other
BioXcel Corporation
Other
Bristol-Myers Squibb Company
Other
Celista Pharmaceuticals LLC
Other
Eleos, Inc.
Other
Genentech, Inc.
Other
Highlight Therapeutics
Other
Incyte Corporation
Other
Instil Bio, Inc.
Other
Learmont Pharmaceuticals, Inc.
Other
Lyell Immunopharma, Inc.
Other
MSD International Business GmbH
Other
Marshall Edwards, Inc.
Other
Memgen LLC
Other
National Cancer Institute, Div of Cancer Treatment & Diagnosis (DCTD)
Other
NewG Lab Pharma, Inc.
Other
Novartis Pharmaceuticals Corporation
Other
OncoTx, LLC
Other
OncoVac Corporation
Other
Oncotelic Inc.
Other
Partner Therapeutics, Inc.
Other
Pfizer, Inc.
Other
Reata Pharmaceuticals, Inc.
Other
Regeneron Pharmaceuticals, Inc.
Other
Sapience Therapeutics, Inc
Other
SciClone Pharmaceuticals, Inc.
Other
SillaJen, Inc.
Other
SolaranRx, Inc.
Other
Takeda Development Center Americas, Inc.
Other
Ultimovacs ASA
Other
Viralytics Limited, a wholly owned subsidiary of Merck Sharp & Dohme, LLC
Other